Sankyo's Percutaneous Absorption-Type Analgesic and Anti-inflammatory Drug Loxonin Poultice 100mg Receives Approval for Manufacture in Japan.Tokyo, Japan, Jan 25, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Sankyo has announced that percutaneous absorption-type analgesic analgesic (ăn'əljē`zĭk), any of a diverse group of drugs used to relieve pain. Analgesic drugs include the nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, narcotic drugs such as morphine, and synthetic drugs and anti-inflammatory preparation Loxonin poultice poultice /poul·tice/ (pol´tis) a soft, moist mass about the consistency of cooked cereal, spread between layers of muslin, linen, gauze, or towels and applied hot to a given area in order to create moist local heat or counterirritation. 100mg, or loxoprofen sodium, jointly developed by Toyama-based Lead Chemical Co., Ltd. and Sankyo has been approved for manufacture on January 23. Among poultice preparations containing nonsteroidal anti-inflammatory drugs Nonsteroidal Anti-Inflammatory Drugs Definition Nonsteroidal anti-inflammatory drugs are medicines that relieve pain, swelling, stiffness, and inflammation. (NSAIDs), it is the first poultice for usage once per day to be granted approval for manufacture. Loxonin poultice is a hydrophilic hydrophilic /hy·dro·phil·ic/ (-fil´ik) readily absorbing moisture; hygroscopic; having strongly polar groups that readily interact with water. hy·dro·phil·ic adj. preparation containing the same constituents as Loxonin pills and Loxonin powder, which is one of the leading brands among orally administered analgesic and anti-inflammatory drugs in Japan. As it is applied once per day, we expect there will be an improvement in user compliance. Sankyo hopes this new addition to the Loxonin brand, which is a long-standing top brand in the Japanese market, will further contribute to analgesic and anti-inflammatory drug treatment. This preparation is scheduled to be manufactured by Lead Chemical and sold by Sankyo. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion